Luis Margusino‐Framiñán

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

Purificación Cid‐Silva, Noelia Fernández Bargiela, Luis Margusino‐Framiñán et al. · Basic & Clinical Pharmacology & Toxicology · 2018 · 48 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Survey on the situation of telepharmacy as applied to the outpatient care in hospital pharmacy departments in Spain during the COVID-19 pandemic.

Begoña Tortajada-Goitia, Ramón Morillo‐Verdugo, Luis Margusino‐Framiñán et al. · PubMed · 2020 · 42 citations · Full text

Pharmacy, Hospital Pharmacy, Pharmacy Practice +13

Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in <scp>HIV</scp>‐infected Patients: Efficacy, Safety and Tolerance

Purificación Cid‐Silva, Josep M. Llibre, Noelia Fernández Bargiela et al. · Basic & Clinical Pharmacology & Toxicology · 2017 · 38 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy.

Luis Margusino‐Framiñán, Aitziber Illarro-Uranga, Karina Lorenzo‐Lorenzo et al. · PubMed · 2020 · 37 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Medicine +1

Late HIV Diagnosis but EarlierAntiretroviral Treatment Initiationin Northwest Spain: Impact of CurrentTreatment Guidelines

Purificación Cid‐Silva, Luis Margusino‐Framiñán, Vanesa Balboa‐Barreiro et al. · 2019 · 31 citations

Public Health, Infectious Diseases, Internal Medicine +15